Collegium Pharmaceutical, Inc. (COLL) vs Helus Pharma Inc. (HELP)
A side-by-side comparison of Collegium Pharmaceutical, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COLL
Collegium Pharmaceutical, Inc.
$22.23HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
HELP
Helus Pharma Inc.
$11.08HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
Total return — COLL vs HELP
growth of $100 · dividends reinvested · last 1yCOLL -53.9% (-53.9%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
COLL HELP
COLL vs HELP: by the numbers
- •COLL is the larger company ($721M vs $687M market cap).
- •HELP converts more revenue to profit (329.09% vs 5.93% net margin).
Metrics side by side
Valuation
| Metric | COLL | HELP |
|---|---|---|
| P/E ratio | 17.93 | N/A |
| PEG ratio | 1.00 | N/A |
| P/S ratio | 0.89 | N/A |
| P/B ratio | 2.31 | 2.84 |
| EV / EBITDA | 2.87 | N/A |
| FCF yield | 45.53% | N/A |
Profitability
| Metric | COLL | HELP |
|---|---|---|
| Gross margin | 60.02% | 100.27% |
| Operating margin | 19.61% | 317.06% |
| Net margin | 5.93% | 329.09% |
| ROE | 15.36% | -75.79% |
| ROIC | 6.11% | -73.27% |
Growth (annualized)
| Metric | COLL | HELP |
|---|---|---|
| Revenue CAGR (5Y) | 19.91% | N/A |
| EPS CAGR (5Y) | 20.48% | N/A |
| FCF CAGR (5Y) | 26.38% | N/A |
| Total return CAGR (5Y) | 2.15% | N/A |
Frequently asked
- Is COLL or HELP more profitable?
- HELP runs the higher net margin — COLL at 5.93% versus HELP at 329.09%.
Go deeper
Dig into the metrics
Collegium Pharmaceutical P/E ratioCollegium Pharmaceutical ROEHelus Pharma ROECollegium Pharmaceutical operating marginHelus Pharma operating marginCollegium Pharmaceutical revenue growthHelus Pharma revenue growthCollegium Pharmaceutical free cash flowHelus Pharma free cash flow
Collegium Pharmaceutical & Helus Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.